Lexicon Pharmaceuticals Inc (NAS:LXRX)
$ 0.7734 -0.01075 (-1.37%) Market Cap: 279.58 Mil Enterprise Value: 122.41 Mil PE Ratio: 0 PB Ratio: 1.57 GF Score: 43/100

Q1 2022 Lexicon Pharmaceuticals Inc Earnings Call Transcript

May 05, 2022 / 12:00PM GMT
Release Date Price: $1.85 (-4.64%)
Operator

Good morning. This is Jesse, and I will be your conference operator today. At this time, I'd like to welcome everyone to the Lexicon Pharmaceuticals Inc. Fourth Quarter 2021 (sic) [First Quarter 2022] Earnings Conference Call.

(Operator Instructions)

I'll now turn the call over to your host, Chas Schultz, Executive Director, Corporate Communications and Investor Relations.

Sir, you may now begin.

Chas Schultz
Lexicon Pharmaceuticals, Inc. - Executive Director of Corporate Communications & Patient Advocacy

Thank you, Jesse. Good morning, and welcome to the Lexicon Pharmaceuticals First Quarter 2022 Financial Results Conference Call. Joining me today are Lonnel Coats, Lexicon's Chief Executive Officer; Jeff Wade, Lexicon's President and Chief Financial Officer; and Dr. Craig Granowitz, Lexicon's Senior Vice President and Chief Medical Officer.

Earlier this morning, Lexicon issued a press release announcing our financial results for the first quarter of 2022, which is available on our website at

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot